Welcome to Shalby Hospital Investor Section
- Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at Edelweiss India Conference (Feb’18):
- Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at IIFL Enterprising India IX-2018 (Feb’18):
- A Special Episode in CNBC Awaaz – Incredible Journey – Rising stars
Disclosure under SEBI PIT Reg. 7(2) Announcement - Dr. Purvish Parikh as -Group Advisor Press Release - Radiation Therapy Centre, Jaipur Press Release - Radiation Therapy Centre, Naroda, Ahmedabad Authorization to KMP under Reg. 30 of SEBI LODR Statement of Investors Complaints – Q3 FY 2017-18 Disclosure under SEBI PIT Reg. 7(2) Intimation about Loss of Share certificates Press Release – MoU with with Gleneagles Global Health City for Heart & Lung Transplants Program
Statement of Investor Complaints – Q4 FY 2017-18 Share Capital Audit – 31-03-2018 Compliance Certificate under Reg. 7(3) of LODR Press Release – MoU with Sen Sok Intl Hospital, Cambodia Certificate under Regulation 40(10) of SEBI LODR Joint Replacement Surgeries under Mukhyamantri Amrutam Yojana Change in CIN Schedule of Investor / Analyst Meet Schedule of Investor / Analyst Meet – 27-04-2018 Intimation Conference Call Intimation Appointment of CDSL as designated depository Collaboration with Berkeley Health Education Investor/Analyst meeting with Motilal Oswal Securities Limited Investors meet/UBS India- Midcap conference Resignation of Chief Executive Officer of the Company Intimation Analyst meet HDFC Securities 26-06-2018 Updates relating to resignation of CEO Man of the Year Award – Dr. Vikram Shah Intimation Analyst meet – 26-06-2018 Intimation Analyst meet - 27-06-2018 Intimation Analyst meet - 02-07-2018 Intimation Analyst meet – 06-07-2018 Intimation Liver Disease and Transplantation Karvy Reconciliation Report Investor Grievance report Intimation of AGM Intimation of Book closure AGM Notice & Annual Report 2017-18 Newspaper Ad. AGM, Book closure & E-voting Outcome of AGM Voting Results Shalby Press Release - Ovarian Mass Removal Jaipur Credit Rating ICRA Reg 30 LODR Reg 30 Orthotrends 2018 Chandigarh Intimation under Regulation 30 of SEBI LODR-concall with Edelweiss Investor Grievance Report Q2 FY 2018-19 Share Capital Audit Q2 FY 2018-19 Compliance Certificate 7(3) – 30-09-2018 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2018-19 Pre Accreditation Entry level NABH at Shalby Surat Intimation for Conference call Submission of newspaper AD – Notice of Board Meeting Pre-Accreditation Entry level NABH at Shalby Naroda Newspaper ad for Issue of Duplicate Shares Intimation Analyst Meet – Nalanda Capital Intimation participation in IDFC Investor Conference Investor conference Kotak Intimation Issue of Duplicate Shares Press Release Kolkata Intimation Transfer of operations Karvy Medical Value Travel Specialist Hospital Award 2018 Best hospital for Medical Tourism in Gujarat Award Share Capital Audit Q3 FY 2018-19 Intimation of Investor Analyst Concall Intimation of Conference Call Intimation Analyst meet - DSP BlackRock Investment Newspaper ad for Q3 FY 2018-19 Results
Intimation of Trading Window Closure Compliance Certificate 7(3)-31-03-2019 Intimation Of Analyst Meet Certificate under Regulation 40(10) of SEBI LODR –H2 FY 2018-19 Reconciliation of Share Capital Q4 2018-19 Interaction with electronic media Recommendation of Dividend for FY 2018-19 Schedule of Investor / Analyst Meet Q4 FY19 Submission of newspaper ad results Q4 FY2018-19 Disclosure under SEBI PIT Reg. 7(2) 30.05.2019 Disclosure under SEBI PIT Reg. 7(2) 01.06.2019 Intimation of Trading Window Closure Best IT enabled Hospital Award Reconciliation of Share Capital Q1 2019-20 Certificate under Regulation 74 (5) Q1 2019-20 Schedule of Investor Conference Call Q1 FY19 News Paper Advertisement PAS-1 AGM Participation in Emkay Confluence at Mumbai – 08-Aug-2019 Participation in Elara Annual Conference at Mumbai-– 05-September-2019 Gujarat HealthCare Leadership Award 2019 Intimation of Trading Window closure – Q2 FY 2019-20 Fin. Results Dare to Dream -Zee Business Award - Company of the Year Credit Rating ICRA Reg 30 LODR Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2019-20 Clarification Of Price Movement Investor Con-call Q2 FY2019-20 Press Release- Q2FY20 Financial Results Submission of newspaper ad results Q2 FY2019-20 Change of name of Registrar & Transfer Agent Intimation of Trading Window closure – Q3 FY 2019-20 Fin. Results Compliance Certificate Q3 30-09-2019 Reconciliation of Share Capital Audit Report Q3 FY 2019-20 Change in Details of RTA Investor Con-call Q3 FY2019-20 Clarification as to increase in volume of shares Re-appointment of CMD Submission of newspaper ad results Q3 FY2019-20 Disclosure under SEBI PIT Reg. 7(2) 26.02.2020
Intimation Of Subsidiary Company Con-call with Investors to address general queries about ongoing COVID-19 pandamic Con-call with Investors hosted by HDFS Sec to address general queries about ongoing COVID-19 pandemic Clarification Of Price MOvement To NSE Clarification Of Price MOvement To BSE Intimation of Testing of COVID-19 cases at Indore Shalby Hospital Con-call intimation hosted by Edelweiss Con-call intimation hosted by Edelweiss Compliance Certificate 7(3) – 31-03-2020 Certificate under Reg.74(5) of SEBI (DP) Regulations, 2018 Treatment of Covid-19 Patient at Shalby Hospital Conference call hosted by Centrum Broking Ltd. Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2019-20 Reconciliation of Share Capital Audit Report Q4 FY 2019-20 Disclosure as to Large Corporate Schedule of Investor / Analyst Meet Q4 FY20 Trading Window Closure Notice For Q1 FY2021 Intimation of Treatment of Covid-19 Patient at Shalby Hospital, Surat Intimation of Treatment of Covid-19 Patient at Shalby Hospital, Vapi Credit Rating ICRA Reg 30 LODR Certificate under Regulation 74 (5) Q1 2020-21 Disclosure of impact of CoVID-19 on the business and operations Reconciliation of Share Capital Audit Report Q1 FY 2020-21 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome” Announcement under Secretarial Compliance Report FY 2019-20” Aquisition Subsidiaries Investor Call Intimation Submission of newspaper ad for results Q1 FY2020-21 Notice of 16th Annual General Meeting Intimation of Board of Directors Meeting Outcome of Board meeting Compliance Certificate 7(3) – 30-09-2020 Certificate under Regulation 74 (5) Q2 2020-21 Investor Conference Call Q2 F.Y. 2020-21 Newspaper Ad for Results Q2 FY 2020-21 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2020-21 Reconciliation of Share Capital Audit Report Q2 FY 2020-21 Investor Analyst Call Intimation Of Subsidiary Company SHMPL Intimation Of Subsidiary Company SHMPL Certificate under Regulation 74 (5) Q3 2020-21 Schedule of Investor / Analyst Meet Q3 FY2021 Shalby Limited Q3 FY2021 Press Release Reconciliation of Share Capital Audit Report Q3 FY 2020-21 Investor / Analyst Meet
Terms of appoitment of Independent Directors
Code of Conduct for Directors & Senior Management
Vigil Mechanism Whistleblower Policy
Nomination and Remuneration Policy
Risk Management Policy
Policy on Criteria for Determining Materiality of Events
Policy for Preservation of Documents
Performance Evaluation Policy for BOD
Material Subsidiary Policy
Director Familiarisation Policy
Familiarization Program Imparted to Independent Directors
Corporate Social Responsibility (CSR) Policy
Related Party Transaction Policy
Revised Code – PIT & Fair Disclosure of UPSI
Business Responsibility Report Policy
Dividend Distribution policy
Financial Year | Q1 | Q2 | Q3 | Q4 | ||||
Board Meeting | Intimation | News Paper Ad. | Intimation | News Paper Ad. | Intimation | News Paper Ad. | Intimation | News Paper Ad. |
2017-18 | – | – | – | – | ||||
2018-19 | ||||||||
2019-20 | ||||||||
2020-21 | – |
Share Holder’s Meeting
General Meeting | Intimation | Book closure / Record date | Advertisement | Outcome | Voting Result | |
14th AGM – 17-09-2018 | ||||||
15th AGM – 26-08-2019 | ||||||
16th AGM – 14-09-2020 | Proceeding | |||||
Postal Ballot Notice dated 09-10-2020 | – | – |
Registered & Corporate Office
Shalby Limited Opposite Karnawati Club, Sarkhej Gandhinagar Highway, Near Prahlad Nagar Garden, Ahmedabad – 380 015, Gujarat, India Phone: +91 79 4020 3000 Fax :+91 79 4020 3120 CIN : L85110GJ2004PLC044667
Listed at NSE & BSE Listing Date December 15, 2017 Scrip Code : NSE – SHALBY BSE – 540797
ISIN INE597J01018 Face Value of Shares ` 10 Outstanding Shares 108,009,770 Financial Year ending March 31 of every year |
Grievance Redressal
The Shareholders may forward their queries/grievances to the Company at the following address : Compliance Officer : Mr. Jayesh Patel Company Secretary and Compliance Officer Email : Companysecretary@shalby.in Tel. No : +91 79 4020 3000 Fax No : +91 79 4020 3120 Website : www.shalby.org |
Registrar & Transfer Agent KFin Technologies Private Limited
KFintech, Tower – B, Plot No 31 & 32, Selenium Building, Financial District, Nanakramguda, Gachibowli, Hyderabad – 500 032, Telangana, India Phone +91- 40 – 67162222 , +91- 40 – 33211000 Investor Grievance E-mail ID : einward.ris@kfintech.com |
Details of Nodal Officer for IEPF
Mr. Jayesh Patel Company Secretary & Compliance Officer Shalby Multi-Specialty Hospitals, Opp. Karnavati Club S. G. Road, Ahmedabad 380015 Phone : +91 79 40203296 Email : companysecretary@shalby.in |
- Shareholding Pattern as on 13-12-2017
- Quarterly Shareholding Pattern
Financial Year | Q1 | Q2 | Q3 | Q4 |
2017-18 | – | – | ||
2018-19 | ||||
2019-20 | ||||
2020-21 | – |